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Abstract:  In  this  work,  we  examined  the  biocompatibility  of  electrospun  chitosan 
microfibers  as  a  scaffold.  The  chitosan  microfibers  showed  a  three-dimensional  pore 
structure  by  SEM.  The  chitosan  microfibers  supported  attachment  and  viability  of  rat 
muscle-derived  stem  cells  (rMDSCs).  Subcutaneous  implantation  of  the  chitosan 
microfibers demonstrated that implantation of rMDSCs  containing chitosan microfibers 
induced lower host tissue responses with decreased macrophage accumulation than did the 
chitosan microfibers alone, probably due to the immunosuppression of the transplanted 
rMDSCs.  Our  results  collectively  show  that  chitosan  microfibers  could  serve  as  a 
biocompatible in vivo scaffold for rMDSCs in rats. 
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1. Introduction  
Tissue engineering has developed as a way to repair and regenerate defective or damaged tissues 
and organs [1]. The typical method is to incorporate various cells into three-dimensional polymer 
scaffolds and to create conditions for the cells to proliferate in vitro and in vivo. The polymer scaffold 
controls the tissue structure by holding the cells together in a particular three-dimensional structure and 
by regulating their biological function [2]. 
Recently,  developing  scaffolds  that  mimic  the  architecture  of  three-dimensional  tissue  at  the 
micro/nanoscale  is  one  of  the  major  challenges  in  the  field  of  tissue  engineering  [3,4].  The  
three-dimensional  scaffolds  at  the  micro/nanoscale  may  serve  as  an  excellent  framework  for  the 
attachment, growth, and differentiation of implanted cells. The three-dimensional scaffolds may also 
provide a suitable environment for the diffusion of nutrients, metabolites and biological factors. Such a 
scaffold,  therefore,  needs  to  be  developed  to  mimic  the  structure  and  biological  functions  of 
extracellular matrices (ECM) [5]. 
Currently,  there  are  three  techniques  available  for  the  fabrication  of  micro/nanoscale  scaffolds: 
electrospinning, self-assembly, and phase separation  [6–8].  Of these techniques, electrospinning  is 
considered as one of the most promising techniques. Therefore, the development of micro/nanoscale 
scaffolds by using electrospinning has greatly enhanced the scope for fabricating scaffolds that can 
fulfill various challenges in terms of tissue engineering applications. The availability of a wide range 
of natural and synthetic biomaterials has broadened the scope for development of micro/nanoscale 
scaffolds  [9,10].  Among  them,  chitosan-based  scaffolds  have  been  shown  to  be  biodegradable,  
non-immunogenic  and  biocompatible, and  thus  are widely used as  therapeutic  scaffolds  for tissue 
engineering processes [11–13]. 
Adult stem cells are self-renewing and pluripotent cells with a plasticity to differentiate into cell 
types of a particular tissue [14]. These adult stem cells have been obtained from various sources such 
as bone marrow, adipose tissue, muscle tissue, and human umbilical cord. Because of its considerable 
mass in the body, skeletal muscle has attracted much attention as a potential source of adult stem cells. 
Muscle-derived stem cells (MDSCs) can be isolated from skeletal muscles and have been shown to 
undergo  multilineage  differentiation  in  vitro  and  in  vivo  upon  stimulation  with  several  biological 
factors [15–17]. Here, we examined the ability of microscale scaffolds prepared by electrospinning of 
chitosan to create a suitable in vitro and in vivo substrate for rat MDSCs (rMDSCs). In addition, we 
evaluated in vivo host tissue responses to rMDSCs-containing chitosan microfibers. 
2. Experimental Section 
2.1. Preparation of Electronspun Chitosan Microfibers 
Chitosan  solution  (5  wt%)  was  prepared  by  dissolving  the  chitosan  (Mw  =  50,000,  degree  of 
deacetylation  =  97%)  in  2  wt%  CH3COOH  solution.  Typically,  electrospinning  was  performed  at  
20 kV voltage, 10 cm distance between the needle tip and the collector (Taksan Meditech Co., Ltd., 
Korea). The flow rate of the solution was controlled by a syringe pump maintained at 10 m/min from 
the needle outlet. A grounded aluminum foil was used as the collector. The microfibrous chitosan was Int. J. Mol. Sci. 2010, 11                     
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collected on the surface of aluminum foil. A porosimeter (Auto Pore IV 9500 V 1.03; Instruments Co., 
USA) was used to examine the porosity and mean pore diameter of the obtained microfibrous chitosan. 
2.2. Rat Muscle-Derived Stem Cell Isolation 
The major hind-limb muscles of the rats were removed, trimmed of excess connective tissue and fat, 
hand minced, and washed twice with PBS. After centrifugation at 2000 rpm for 5 min, the resultant 
pellets were enzymatically
 dissociated by adding 0.2% collagenase-type XI (Sigma, Germany) for 1 h 
at 37 ° C,
 dispase (20 mL, Gibco BRL) for 45 min, and 0.1% trypsin (Sigma, Germany) for 30 min. 
Cells were separated from muscle fiber fragments and tissue debris by differential centrifugation and 
were plated on collagen-coated
 flasks in DMEM containing 5% fetal bovine serum (Gibco BRL), 5% 
horse serum (Gibco BRL), penicillin (100 U/mL), and streptomycin (100 μg/mL) for 1 h. The muscle 
cell extract was pre-plated on collagen-coated
 flasks. Unattached cells floating in the medium after 1 h 
incubation were then transferred onto fresh collagen-coated
 flasks. The subsequent pre-plates were 
performed in the next 2 h, 3 h, 1 day, 2 days and 3 days. Finally, the rMDSCs were seeded into normal 
tissue culture flasks at 1 ×  10
5 cells/cm
2. The flasks were rinsed three times with PBS on the second 
day of expansion. The medium was changed every 2 days throughout the studies. Adherent cells, 
rMDSCs, were rinsed thoroughly with PBS and detached by 0.05% trypsin-EDTA for experiment use. 
The final rMDSCs used were taken at passage 5.  
2.3. PKH67 Cell Labeling 
The rMDSCs were labeled using the PKH67 Fluorescent Cell Linker Kit (Sigma, USA) according 
to the manufacturer’s instructions. In brief, the cultured rMDSCs were washed with serum-free media 
and centrifuged for 5 min at 400 g. The provided diluent C (500 μL) was added to 3 ×  10
5 rMDSCs 
and  immediately  mixed  with  500  μL  of  PKH67  stock  solution  (4  ×  10
-6  M)  in  diluent  C.  After 
incubation for 5 min at room temperature, 1 mL of FBS was added and samples were incubated for  
1 min to stop the labeling reaction. Finally, the rMDSCs were pelleted for 5 min at 400 g, transferred 
to a fresh tube and washed three times with complete DMEM. 
2.4. Cell Culture on Electronspun Chitosan Microfibers 
Electronspun chitosan microfibers were sterilized by EO gas at Hansbiomed Company. For cell 
culture experiments, the chitosan microfibers were prepared and placed individually into the wells of a 
24-well tissue culture plate (Falcon, USA) and then incubated for 1 h in culture media. After suction of 
the media, the PKH67 labeled rMDSCs (3 ×  10
4 cells/well) were transferred to each well. The culture 
media was changed every 2 days throughout the studies. For SEM measurements, at 1 and 7 days, the 
microfibrous  scaffolds  without  or  with  rMDSCs  were  fixed  with  2.5%  glutaraldehyde  for  24  h, 
followed by ethanol dehydration. The fixed chitosan microfibers were coated with a conductive layer 
of  gold  using  a  plasma-sputtering  apparatus  (Emitech,  K575,  Kent,  UK),  and  scanning  electron 
microscopy (SEM, S-2250N, Hitachi, Japan) images were obtained. Cytotoxicity was measured using 
a WST-1 kit (Roche, Germany) after 1, 3, and 7 days. Briefly, 100 μL of WST-1 reagent was added to 
rMDSCs in 1 mL medium per well, the plates were incubated at 37 
oC for 4 h, and the samples were Int. J. Mol. Sci. 2010, 11                     
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then shaken for 1 min. An aliquot from each well (100 μL) was transferred to a 96-well plate, and 
absorbance at 450 nm was measured with a microplate reader (EL808 ultra microplate reader; Bio-Tek 
Instrument, USA). 
2.5. Animal Implantation Surgery  
The rats were housed in sterilized cages with sterile food, water and filtered air, and were handled 
under a laminar flow hood following aseptic techniques. All animals were treated in accordance with 
the Institutional Animal Experiment Committee at Ajou University School of Medicine. Twenty-four 
Fischer rats (140–160 g, 4 weeks), divided into four groups of three rats each, were used in the animal 
tests.  The  chitosan  microfibers  without  and  with  rMDSCs  (3  ×   10
4  cells)  were  implanted 
subcutaneously under the dorsal skin and then allowed to develop, and biopsied in vivo over 4 weeks. 
At  each  of  the  post-implantation  points,  the  rats  were  sacrificed  and  the  implants  were  dissected 
individually and removed from the subcutaneous dorsum. 
2.6. In Vivo SEM Measurements 
SEM  was  used  to  examine  morphology  of  in  vivo  chitosan  microfibers.  The  in  vivo  chitosan 
microfibers without or with rMDSCs after 1 and 4 weeks were fixed with 2.5% glutaraldehyde for  
24 h, followed by ethanol dehydration. The fixed chitosan microfibers were coated with a conductive 
layer of gold using a plasma-sputtering apparatus (Emitech, K575, Kent, UK), and scanning electron 
microscopy (SEM, S-2250N, Hitachi, Japan) images were obtained.  
2.7. Histological Analysis 
At 3 days, one, two and four weeks after implantation, the rats were sacrificed and the implants 
were  individually  dissected  and  removed  from  the  subcutaneous  dorsum.  The  implants  were 
immediately  fixed  with  10%  formalin  and  embedded  in  paraffin.  The  embedded  specimens  were 
sectioned  (4  µm)  along  the  longitudinal  axis  of  the  implant,  and  the  sections  were  stained  with 
hematoxylin  and  eosin  (H&E),  6-diamino-2-phenylindoadihydrochloride  (DAPI,  Sigma-Aldrich,  St 
Louis,  MO,  USA),  and  mouse  anti-rat  CD68  (ED1;  1:1000;  Serotec,  Oxford,  UK).  The  staining 
procedures for DAPI and ED1 were as follows. The slides were washed with PBS-T (0.05% Tween 20 
in PBS), blocked with 5% bovine serum albumin (BSA; Roche, Mannheim, Germany) and 5% horse 
serum (HS; GIBCO, Paisley, UK) in PBS for 1 h at 37 
oC. The sections were incubated overnight at  
4 
oC with ED1 antibodies, washed with PBS-T, and then incubated with the secondary antibody (goat 
anti-mouse Alexa Fluor
®594; Invitrogen, San. Diego, CA, USA) for 3 h at room temperature in the 
dark. The slides were washed again with PBS-T, counterstained with DAPI, and then mounted with 
fluorescent mounting solution (DAKO, Calif, USA). Immunofluorescent images were visualized under 
an Axio Imager A1 (Carl Zeiss Microimaging GmbH, Gö ttingen, Germany) equipped with Axiovision 
Rel.  4.8  software  (Carl  Zeiss  Microimaging  GmbH,  Gö ttingen,  Germany).  Before  acquisition  of 
immunofluorescent images, the delimitation between implant and host tissue was determined from a 
differential interference contrast (DIC) optical microscopic image. The sections were also stained with 
hematoxylin and eosin (H&E) using standard procedures. Int. J. Mol. Sci. 2010, 11                     
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2.8. Statistical Analysis 
Cytotoxicity data were obtained from independent experiments in which three wells per culture 
plate  or  chitosan  microfibers  were  examined  and  ED-1  assays  were  carried  out  in  independent 
experiments with n = 16 for each data point, with data given as the mean and standard deviation (SD). 
Statistical analysis using the one-way ANOVA method was carried out with Bonferroni’s multiple 
comparisons.  
3. Results and Discussion  
In this work, electrospun chitosan microfibers exhibited randomly arranged structures. Figure 1a 
shows a SEM image. The electrospun chitosan microfiber had an average diameter of ~10 μm, pore 
diameter of 22 μm, and porosity of 90%. Adequate three-dimensional structure and porosity is required 
not only to achieve sufficient cell seeding conditions within the chitosan microfibers as a scaffold, but 
also to facilitate cell proliferation and differentiation by allowing the transport of nutrients and oxygen 
into and out of the chitosan microfiber scaffold. 
Figure 1. SEM images of (a) chitosan microfiber only, (b) rMDSCs seeded on chitosan 
microfiber  at  1  day,  and  fluorescence  images  of  PHK67  labeled  rMDSCs  seeded  on 
chitosan microfiber at (c, d) 1 and (e, f) 7 days. Magnification: (a, b) 300 x, (c, e) 50 x and 
(d, f) 100 x. Scale bars: (a, b) 100 μm, (c, e) 200 μm and (d, f) 100 μm. rMDSCs viability 
on chitosan microfiber measured by WST-1 assay (g). rMDSCs grown on a plain culture 
plate were used as the control (* p < 0.005). 
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In order to examine the rMDSCs attaching and proliferation on the chitosan microfibers after 1 and 
7 days, rMDSCs attaching and proliferation on the chitosan microfibers were examined by SEM and 
fluorescence  microscopy.  SEM  images  showed  the  morphology  of  the  rMDSCs  attaching  on  the 
chitosan microfibers after 1 day (Figure 1b). The fluorescence image of PHK67 labeled rMDSCs was 
observed  on  the  chitosan  microfibers  (Figure  1c–f).  The  number  of  green  images  increased  with 
increasing incubation time. The green fluorescence images mean the PHK67 labeled rMDSCs. 
We evaluated the cytotoxicity of in vitro cultured rMDSCs on chitosan microfibers over a period of 
7 days (Figure 1g). For comparison, identical experiments were carried out on fibers-free tissue culture 
plates. The number of rMDSCs generally increased on both the chitosan microfibers and the tissue 
culture plate (control) (* p < 0.005). Therefore, we found that chitosan microfibers were biocompatible 
substrates for the attachment and proliferation of rMDSCs, even though significantly more rMDSCs 
were counted on the tissue culture plate compared to the chitosan microfibers on 1, 3, and 7 days. 
Figure 2. Optical (upper) and SEM (bottom) images of chitosan microfibers removed from 
rats after (a, a’) 3 days, (b, b’) 1 week, (c, c’) 2 weeks, and (d, d’) 4 weeks.  
 
 
To  examine  the  utility  of  chitosan  microfibers  as  in  vivo  scaffolds,  we  implanted  chitosan 
microfibers without and with rMDSCs subcutaneously into rats. The implants were allowed to develop 
for up to four weeks in vivo, and were excised and examined at various times post-implantation. The 
resulting implants maintained their shapes even after four weeks in vivo (Figure 2a–d). In addition, 
vascular blood vessels formed around the surfaces of the implants over time after implantation. SEM 
images showed chitosan microfibers interspersed with connective tissues and cells (Figure 2a’–d’). 
To observe in vivo chitosan microfibers as a scaffold in more detail, we performed histological 
staining of tissue within and near the implanted chitosan microfibers of rats 3 days, 1, 2 and 4 weeks 
post-implantation. H&E staining of chitosan microfibers (red) could be clearly distinguished from the 
host  tissue  layer.  New  blood  vessels  were  observed  in  chitosan  microfibers,  in  which  the  arrows 
indicate newly formed blood vessels (Figure 3a–h, upper).  
The extent of host cell infiltration and inflammatory cell accumulation within and surrounding the 
chitosan  microfibers  was  also  characterized  by  staining  tissue  with  ED1  (red)  to  identify 
monocytes/macrophages; nuclei were stained with DAPI (blue) (Figure 3i–p, bottom). DAPI staining 
revealed the presence of numerous host cells within and surrounding the chitosan microfibers. ED1 Int. J. Mol. Sci. 2010, 11                     
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staining showed that macrophages were present in chitosan microfibers. The ED1-positive cells were 
counted  and  normalized  to  the  total  stained  tissue  area  to  determine  the  extent  of  inflammation  
(Figure  4).  The  number  of  macrophages  (ED1-positive  cells)  decreased  slightly  with  increasing 
implant duration (*p < 0.05). The rats  receiving rMDSCs-containing chitosan microfibers  showed 
slightly  less  macrophages  than  chitosan  nanofiber  only,  due  to  the  unique  immunomodulatory 
properties of stem cells [18–20]. In addition, the extent of inflammation of chitosan microfibers with 
and without rMDSCs was less pronounced than that to the FDA-approved poly(lactic-co-glycolic acid) 
(PLGA) [21,22]. 
Figure 3. H&E (a–h) and ED1 immunofluorescence (i–p) staining of chitosan microfibers 
(a–d, i–l) without and (e–h, m–p) with rMDSCs removed from rats after (a, e, i, m) 3 days, 
(b, f, j, n) 1 week, (c, g, k, o) 2 weeks, and (d, h, l, p) 4 weeks. Scale bar is 50 μm. 
 
Figure 4. The number of ED1-positive cells on chitosan microfibers at 3 day, 1 week, 
2 weeks and 4 weeks post implantation (* p < 0.05).  
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4. Conclusions 
We herein prepared chitosan microfibers as a scaffold. It has a three-dimensional pore structure to 
support attachment and  viability of rMDSCs. The  implantation of chitosan microfibers  containing 
rMDSCs  induced  lower  host  tissue  responses  than  did  the  chitosan  microfibers  alone.  This  result 
showed that chitosan microfibers could be used as a biocompatible in vivo scaffold for rMDSCs in rats. 
Further research on the animal model with body defect for comparing biocompatibility of chitosan 
microfibers prepared in this work will be reported on in the future. 
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